![Alastair Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alastair Smith
Président chez
THERACRYF PLC
Fortune : 2 M $ au 31/05/2026
Profil
Alastair MacLaughlin Smith was the founder of Avacta Group Plc, founded in 2004, where the title held was Chief Executive Officer & Executive Director from 2005 to 2024.
Current jobs include Non-Executive Chairman at SPARTA Biodiscovery Ltd., Non-Executive Chairman at TheraCryf Plc starting in 2025, and Independent Non-Executive Director at N4 Pharma Plc starting in 2025.
Former jobs include Chief Executive Officer & Director at Avacta Life Sciences Ltd., Director-Institute of Molecular Biophysics at the University of Leeds, and Director at TheraGenetics Ltd. Education includes undergraduate and doctorate degrees from The University of Manchester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVACTA GROUP PLC 0,36 % | 04/06/2025 | 1 565 100 ( 0,36 % ) | 2 M $ | 31/05/2026 |
THERACRYF PLC 0,19 % | 31/03/2025 | 4 000 000 ( 0,19 % ) | 12 960 $ | 31/05/2026 |
Postes actifs de Alastair Smith
| Sociétés | Poste | Début |
|---|---|---|
| THALIA THERAPEUTICS PLC | Directeur/Membre du Conseil | 08/01/2025 |
| THERACRYF PLC | Président | 19/02/2025 |
Sparta Biodiscovery Ltd.
 Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Président | - |
Anciens postes connus de Alastair Smith
| Sociétés | Poste | Fin |
|---|---|---|
| AVACTA GROUP PLC | Fondateur | 01/05/2024 |
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
TheraGenetics Ltd.
 TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Directeur/Membre du Conseil | - |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Alastair Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Health Technology |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Health Technology |
